Muscle loss and skin looseness are real risks with rapid GLP-1 weight loss, and addressing them is central to how Rescu runs the program rather than an afterthought
Eli Lilly announced positive topline results from the Phase 3 TRIUMPH-4 clinical trial evaluating the safety & efficacy of Retatrutide, a first-in-class GIP, GLP-1 & glucagon triple hormone receptor agonist, in adults with obesity or overweight & knee osteoarthritis
Conclusions and perspectives Mast cell activation is implicated in neuroinflammation, brain injuries, and various stress conditions
Bhat, O
Monitoring Blood glucose levels A1C testing Weight changes Symptoms of pancreatitis or thyroid issues Who This Medication Is For Semaglutide is prescribed for: Adults with type 2 diabetes needing improved blood sugar control Adults with type 2 diabetes and established cardiovascular disease Adults with obesity or overweight with related health conditions (depending on formulation approval) It is intended for chronic management under medical supervision
If your primary goal is more significant weight loss or you have established cardiovascular disease, Wegovy is typically the stronger option
